2022
DOI: 10.3390/pharmaceutics14071315
|View full text |Cite
|
Sign up to set email alerts
|

Galactosed and Reduction-Responsive Nanoparticles Assembled from Trimethylchitosan–Camptothecin Conjugates for Enhanced Hepatocellular Carcinoma Therapy

Abstract: The targeted delivery of drugs to tumor cells and prevention of premature release before reaching the target is one of the key challenges to developing nanomedicines. In this paper, galactose decorated trimethyl chitosan (GT)–camptothecin (CPT) prodrug nanoparticles (GT-ss-CPT NPs) were prepared from GT-CPT conjugates linked by dithiodipropionic acid. The obtained GT-ss-CPT NPs were spherical with a particle size of 184.1 nm. GT-ss-CPT NPs displayed low drug release under physiological conditions, whereas effi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 38 publications
0
4
0
Order By: Relevance
“…N,N,N-trimethyl chitosan (TMC) is a chitosan derivative containing permanent positive charges of quaternary salts on C2 of the main backbone. This chemical modi cation enhances the biological properties such as antimicrobial, anticoagulant, antioxidant and mucoadhesive, making TMC an attractive biopolymer for tissue engineering, wound dressings and hygiene related textiles [13,19,[56][57][58][59][60][61].…”
Section: Discussionmentioning
confidence: 99%
“…N,N,N-trimethyl chitosan (TMC) is a chitosan derivative containing permanent positive charges of quaternary salts on C2 of the main backbone. This chemical modi cation enhances the biological properties such as antimicrobial, anticoagulant, antioxidant and mucoadhesive, making TMC an attractive biopolymer for tissue engineering, wound dressings and hygiene related textiles [13,19,[56][57][58][59][60][61].…”
Section: Discussionmentioning
confidence: 99%
“…Notwithstanding, its broader therapeutic application is hindered by several poor clinical outcomes ascribed to this drug such as low bioavailability and systemic toxicity. In this regard, various modifications of CPT have been reported in the last years. A wide range of chemical moieties have been conjugated at the hydroxy group in the α position of the lactone functional group to improve its antitumoral effects. Interestingly, two Se prodrugs ( 27 and 28 ) (Figure ) have been synthesized by the introduction of a diselenide moiety in this drug structure and have exhibited significantly higher cytotoxic effects to different cancer cell lines compared to CPT (Table ). Furthermore, these CPT analogues unveiled efficient in vivo antitumoral activities and good tolerance in a mouse model compared to the parent drug …”
Section: Selenized Small Molecule Drugsmentioning
confidence: 99%
“…Hemoglobin-curcumin nanostructures have been shown to be advantageous in reducing invasion of HCC cells, suppressing vascular mimics and enhancing radio-sensitivity in hypoxic tumor microenvironment via inhibiting growth and DNA damage repair [92] . Trimetylchitosan-camptothecin conjugates can be considered as reduction-sensitive nanostructures in HCC suppression, providing targeted delivery of drug, reducing premature release and inhibiting tumor growth in vitro and in vivo [93] . Hence, nanostructures are promising candidates for sustained delivery of drugs in HCC therapy [94] .…”
Section: Hepatocellular Carcinoma: An Overviewmentioning
confidence: 99%